Skip to content
healthcare.dev
Get a free key

Lisdexamfetamine dimesylate

NDC 70010-217, Lisdexamfetamine dimesylate, tablet, chewable, from Granules Pharmaceuticals Inc..

Product NDC
70010-217
Status
Listed
Labeler
Granules Pharmaceuticals Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219258
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70010-217 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE40 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
70010-217-0170010021701100 TABLET, CHEWABLE in 1 BOTTLE (70010-217-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c56b4712-2fb8-4c7a-bfbd-0401d9f5f92a

  • NADAC price for package 70010021701

    GET /v1/drugs/nadac/70010021701

Use it

Look up 70010-217 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70010-217 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70010-217. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.